<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04291794</url>
  </required_header>
  <id_info>
    <org_study_id>tccgui2019</org_study_id>
    <nct_id>NCT04291794</nct_id>
  </id_info>
  <brief_title>Mean Arterial Pressure Reduction Anesthesia Induction Using Propofol Bolus or Tritiated Target-infusion</brief_title>
  <official_title>Mean Arterial Pressure Reduction During the First Ten Minutes After General Anesthesia Induction Using Propofol Bolus or Tritiated Target-infusion: Superiority Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brasilia University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brasilia University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare haemodynamics and bispectral index values between conventional bolus propofol
      induction and target-controlled propofol infusion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To compare mean arterial pressure, heart rate and bispectral index values between
      conventional bolus propofol induction and target-controlled propofol infusion.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2020</start_date>
  <completion_date type="Anticipated">November 27, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 25, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Participant and outcomes Assessor will not know group allocation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Mean arterial pressure after 2 minutes</measure>
    <time_frame>2 minutes after general anesthesia induction</time_frame>
    <description>Mean arterial pressure using non-invasive device</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean arterial pressure after 4 minutes</measure>
    <time_frame>4 minutes after general anesthesia induction minutes after general anesthesia induction</time_frame>
    <description>Mean arterial pressure using non-invasive device</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean arterial pressure after 6 minutes</measure>
    <time_frame>6 minutes after general anesthesia induction minutes after general anesthesia induction</time_frame>
    <description>Mean arterial pressure using non-invasive device</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean arterial pressure after 8 minutes</measure>
    <time_frame>8 minutes after general anesthesia induction minutes after general anesthesia induction</time_frame>
    <description>Mean arterial pressure using non-invasive device</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean arterial pressure after 10 minutes</measure>
    <time_frame>10 minutes after general anesthesia induction minutes after general anesthesia induction</time_frame>
    <description>Mean arterial pressure using non-invasive device</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart Rate after 2 minutes</measure>
    <time_frame>2 minutes after general anesthesia induction</time_frame>
    <description>Heart rate (pulse rate) using non-invasive device.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate after 4 minutes</measure>
    <time_frame>4 minutes after general anesthesia induction</time_frame>
    <description>Heart rate (pulse rate) using non-invasive device.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate after 6 minutes</measure>
    <time_frame>6 minutes after general anesthesia induction</time_frame>
    <description>Heart rate (pulse rate) using non-invasive device.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate after 8 minutes</measure>
    <time_frame>8 minutes after general anesthesia induction</time_frame>
    <description>Heart rate (pulse rate) using non-invasive device.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate after 10 minutes</measure>
    <time_frame>10 minutes after general anesthesia induction</time_frame>
    <description>Heart rate (pulse rate) using non-invasive device.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bispectral Index after 2 minutes</measure>
    <time_frame>2 minutes after general anesthesia induction</time_frame>
    <description>Bispectral Index (BIS) using non-invasive device. At values near 100 mean patient is more likely to be awake and at values below 60 are more likely to be under general anesthesia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bispectral Index after 4 minutes</measure>
    <time_frame>4 minutes after general anesthesia induction</time_frame>
    <description>Bispectral Index (BIS) using non-invasive device. At values near 100 mean patient is more likely to be awake and at values below 60 are more likely to be under general anesthesia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bispectral Index after 6 minutes</measure>
    <time_frame>6 minutes after general anesthesia induction</time_frame>
    <description>Bispectral Index (BIS) using non-invasive device. At values near 100 mean patient is more likely to be awake and at values below 60 are more likely to be under general anesthesia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bispectral Index after 8 minutes</measure>
    <time_frame>8 minutes after general anesthesia induction</time_frame>
    <description>Bispectral Index (BIS) using non-invasive device. At values near 100 mean patient is more likely to be awake and at values below 60 are more likely to be under general anesthesia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bispectral Index after 10 minutes</measure>
    <time_frame>10 minutes after general anesthesia induction</time_frame>
    <description>Bispectral Index (BIS) using non-invasive device. At values near 100 mean patient is more likely to be awake and at values below 60 are more likely to be under general anesthesia.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Hypotension on Induction</condition>
  <condition>Hypnotic Intoxication</condition>
  <arm_group>
    <arm_group_label>Conventional bolus induction</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Hypnotic component of general anesthesia induction will be a single bolus of propofol 2mg/kg followed by turning on sevoflurane 2% at a fresh gas flow of 2L/min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Target-controlled induction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hypnotic component of general anesthesia induction will be target-controlled propofol infusion tritiated to loss of consciousness. Propofol target-controlled infusion will be maintained.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>2mg/kg single bolus</description>
    <arm_group_label>Conventional bolus induction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol Injection [Diprivan]</intervention_name>
    <description>Tritiated Target-Controlled Infusion</description>
    <arm_group_label>Target-controlled induction</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled for general anesthesia;

          -  No contraindication for propofol.

        Exclusion Criteria:

          -  Data loss;

          -  Protocol violation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gabriel MN Guimaraes, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gabriel MN Guimaraes, MSc</last_name>
    <phone>+5561996455997</phone>
    <email>gabrielmng@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universit√°rio de Brasilia</name>
      <address>
        <city>Brasilia</city>
        <state>Distrito Federal</state>
        <zip>70000000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 26, 2020</study_first_submitted>
  <study_first_submitted_qc>February 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 2, 2020</study_first_posted>
  <last_update_submitted>February 28, 2020</last_update_submitted>
  <last_update_submitted_qc>February 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brasilia University Hospital</investigator_affiliation>
    <investigator_full_name>Gabriel Magalhaes Nunes Guimaraes</investigator_full_name>
    <investigator_title>Voluntary professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Plan to share at open database.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>After study ends</ipd_time_frame>
    <ipd_access_criteria>Open</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

